Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Growth Shares
Why I would buy Altium and these ASX tech shares this week
Share Gainers
Why AVITA Medical, Bellamy's, Evolution, & Volpara shares dropped into the red today
Share Fallers
Why Bank of Queensland, BWX, Sims, & Volpara shares dropped lower today
⏸️ ASX Shares
Why I would buy Nanosonics and these ASX healthcare shares
Speculative
Are these small cap ASX tech shares the next Altium and Appen?
Share Gainers
Why Atomos, Avita Medical, Resolute, & Volpara shares surged higher today
Share Gainers
Why exciting small cap tech share Atomos is surging higher on Monday
Share Gainers
Volpara share price has rocketed 11% after beating its FY 2019 guidance: Time to invest?
Growth Shares
Are these small cap ASX tech shares the next Appen?
Share Gainers
Why the Volpara share price is on fire
Share Gainers
Why the Volpara share price rocketed 12% higher today
Share Gainers
Why Pilbara Minerals, Super Retail, Syrah, & Volpara shares stormed higher today
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.
